Russell James Hubbard Ryan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Russell James Hubbard Ryan has a total of 459 co-authors. Here are the top co-authors by number of shared publications:
- Rohan Kodgule
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
43 shared publications - Alec Chu
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
36 shared publications - Marcin P. Cieslik
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
36 shared publications - Noah A. Brown
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
36 shared publications - Aishwarya Gurumurthy
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
35 shared publications - Ashwin Iyer
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
35 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by Elsevier in Blood Neoplasia
EZH2-driven immune evasion at disease presentation defines high-risk t(16;21) FUS::ERG pediatric AML
- 26 September 2026
- Published by Elsevier in Blood Neoplasia
Open AccessEZH2-driven immune evasion at disease presentation defines high-risk t(16;21) FUS::ERG pediatric AML
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Information file from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Contains Supplementary Figures 1-12 and additional information about Supplementary tables
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information file from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Contains Supplementary Figures 1-12 and additional information about Supplementary tables
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary table 4 lists ETV6-regulated gene-enhancer linkages
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary table 4 lists ETV6-regulated gene-enhancer linkages
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 1 lists oligonucleotide sequences and cell line information
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 1 lists oligonucleotide sequences and cell line information
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 5 annotates genome-wide candidate ETV6-repressed enhancers
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 5 annotates genome-wide candidate ETV6-repressed enhancers
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 2 details known and de novo motif analysis for distal acetylation clusters
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 2 details known and de novo motif analysis for distal acetylation clusters
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 3 summarizes TF ChIP-Seq results and motif enrichment statistics
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 3 summarizes TF ChIP-Seq results and motif enrichment statistics
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 6 details GGAA repeat overlap analysis of new and previously published ETS factor datasets.
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Supplementary Table 6 details GGAA repeat overlap analysis of new and previously published ETS factor datasets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Demographic and clinical diagnostic information about DLBCL patient biopsies used for Hi-C and H3K27ac ChIP-Seq
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Demographic and clinical diagnostic information about DLBCL patient biopsies used for Hi-C and H3K27ac ChIP-Seq
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Significant peaks of sgRNA enrichment or depletion identified in sliding-window analysis of MYC locus tiling CRISPRi screens
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Significant peaks of sgRNA enrichment or depletion identified in sliding-window analysis of MYC locus tiling CRISPRi screens